Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenografts.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples